{"text": "fda accepts #amgen's biologics license application for aimovig. read more: URL $amgn"}
{"text": "rt AT_USER $amgn monthly rsi breaking downtrend as looks to leave 40 point range trade URL"}
{"text": "#fda accepted reviewing $amgn\u00a1\u00afs erenumab for patients experiencing four or more #migraine days per month URL"}
{"text": "rt AT_USER $amgn, $nvs amped about fda acceptance of 1st bla filing of cgrp receptor antagonist in migraine; more jockeying likely befor\u00a1\u00ad"}
{"text": "biotechs on a hot streak and could be \"cooking with gas\" $amgn $celg $biib $alxn $srpt $vrtx $gild URL"}
{"text": "rt AT_USER 5 things for #pharma #marketers to know: fri., july 21 #fda #multiplesclerosis $mnk $nvs $azn $amgn #migraine $teva URL"}
{"text": "5 things for #pharma #marketers to know: fri., july 21 #fda #multiplesclerosis $mnk $nvs $azn $amgn #migraine $teva\u00a1\u00ad URL"}
{"text": "rt AT_USER $amgn monthly rsi breaking downtrend as looks to leave 40 point range trade URL"}
{"text": "rt AT_USER $amgn monthly rsi breaking downtrend as looks to leave 40 point range trade URL"}
{"text": "daily #fundamentalanalysis report is out! $nvs $amgn are amongst #stocks downgraded today! &gt;&gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "daily #fundamentalanalysis report is out! $nvs $amgn are amongst #stocks downgraded today! &gt;&gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "daily #fundamentalanalysis report is out! $nvs $amgn are amongst #stocks downgraded today! &gt;&gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "daily #fundamentalanalysis report is out! $nvs $amgn are amongst #stocks downgraded today! &gt;&gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "daily #fundamentalanalysis report is out! $nvs $amgn are amongst #stocks downgraded today! &gt;&gt;&gt;&gt;\u00a1\u00ad URL"}
{"text": "$amgn is up 23% this year, beating $spy $gild $celg $vrx $jnj #stocks #biotech #bigpharma URL"}
{"text": "$amgn, $nvs file bla for #erenumab (#aimovig), 1st #cgrpihibitor may be available 2q18 URL via AT_USER"}
{"text": "$amgn monthly rsi breaking downtrend as looks to leave 40 point range trade URL"}
{"text": "#amgen release: fda accepts biologics license application for aimovig (erenumab)  . read more: URL $amgn"}
{"text": "$amgn max pain = 172.50. maturity = 07/28/2017. previous close = 179.32.  URL URL"}
{"text": "#amgen asks court to weigh in on dupixent, claims infringement. read more: URL $amgn"}
{"text": "amgn top news - jul 21st, 2017 $amgn URL"}
{"text": "AT_USER $rdus i am not sure if people are panicking due to ceo change and looks overdone. i am adding here after $amgn crl!"}
{"text": "throwing this one out to the universe how much resistance is at $180 for $amgn?"}
{"text": "rt AT_USER $amgn, $nvs amped about fda acceptance of 1st bla filing of cgrp receptor antagonist in migraine; more jockeying likely befor\u00a1\u00ad"}
{"text": "we'll see! $ibm $aapl $fb $prgo $amgn $gsk $myl $mrk $bmy $grub $twtr $ko $pep $brk $cmg $iep $goog $amzn $jpm $wfc\u00a1\u00ad URL"}
{"text": "$amgn, $nvs amped about fda acceptance of 1st bla filing of cgrp receptor antagonist in migraine; more jockeying likely before may pdufa"}
{"text": "$fbio breaks the 5$ mark we think it moves much higher very soon $mrk $kite $juno $clls $nvs $pfe $amgn $ziop $zsan $oncs $amrn $fb $cala $f"}
{"text": "all these up nicely.. taking profits as it hits targets. $ibb $xbi $gild $celg $biib $alxn $amgn $regn"}
{"text": "fda to review bla for #amgen-novartis migraine prevention treatment. read more: URL $amgn"}
{"text": "AT_USER been adding to $gild; never sold a share last 2 yrs, i think your right on $gild $celg they go higher. also $amgn $biib"}
{"text": "#amgen announces webcast of 2017 second quarter financial results  . read more: URL $amgn"}
